$GBR Balance Sheet | Understand Stock

$GBR

$0.67 +$0.01 (1.82%) Close

$GBR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets
Cash and cash equivalents
Current portion note receivable (including $3,637 and $3,631 in 2021 and 2020 from related parties
Current portion note receivable (including $3,560 and $3,631 in 2021 and 2020 from related parties)
Accounts Receivable
Note receivable -related parties
Note receivable and accrued interest from related party
Note receivable - related party
Other current assets
Total current assets

Property and equipment, net of depreciation
Land, buildings and equipment
Note receivable -related parties
Note receivable
Interest receivable
Note and interest receivable - related party
Note receivable
Interest receivable
Note and interest receivable - related party
Total assets
Liabilities and stockholders' equity
Current liabilities
Accounts payable (including $8 due to related parties in 2026 and 2025)
Accrued expenses
Total current liabilities
Total liabilities
Stockholders' equity
Preferred stock, Series B, $10 par value; authorized 100,000 shares, 1 issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $.01 par value; authorized, 100,000,000 shares; issued and outstanding, 5,131,934 shares at June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments